In dialysis patients, sclerostin was negatively correlated with iPTH [32, 33], which may be related to the suppression of sclerostin production by osteocytes, or the decrease of bone mass in secondary hyperparathyroidism [32]. Here, SOST is linked to secondary hyperparathyroidism.